nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4B—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.0116	0.221	CbGpPWpGaD
Esomeprazole—ATP4A—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.0104	0.197	CbGpPWpGaD
Esomeprazole—Eruption—Furosemide—dilated cardiomyopathy	0.0103	0.0109	CcSEcCtD
Esomeprazole—Leg pain—Lisinopril—dilated cardiomyopathy	0.0103	0.0109	CcSEcCtD
Esomeprazole—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00996	0.0105	CcSEcCtD
Esomeprazole—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00937	0.00989	CcSEcCtD
Esomeprazole—Apathy—Furosemide—dilated cardiomyopathy	0.00886	0.00935	CcSEcCtD
Esomeprazole—Flat affect—Furosemide—dilated cardiomyopathy	0.00878	0.00926	CcSEcCtD
Esomeprazole—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.00847	0.00894	CcSEcCtD
Esomeprazole—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00826	0.00872	CcSEcCtD
Esomeprazole—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.00798	0.00842	CcSEcCtD
Esomeprazole—Glycosuria—Furosemide—dilated cardiomyopathy	0.00781	0.00824	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0076	0.00802	CcSEcCtD
Esomeprazole—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0076	0.00802	CcSEcCtD
Esomeprazole—Gastritis—Spironolactone—dilated cardiomyopathy	0.00747	0.00788	CcSEcCtD
Esomeprazole—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.00739	0.0078	CcSEcCtD
Esomeprazole—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00691	0.00729	CcSEcCtD
Esomeprazole—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00682	0.0072	CcSEcCtD
Esomeprazole—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00672	0.00709	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00645	0.00681	CcSEcCtD
Esomeprazole—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00644	0.0068	CcSEcCtD
Esomeprazole—Renal failure—Spironolactone—dilated cardiomyopathy	0.00639	0.00675	CcSEcCtD
Esomeprazole—Otitis media—Lisinopril—dilated cardiomyopathy	0.0061	0.00643	CcSEcCtD
Esomeprazole—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00607	0.00641	CcSEcCtD
Esomeprazole—Urine output increased—Furosemide—dilated cardiomyopathy	0.00572	0.00604	CcSEcCtD
Esomeprazole—Bladder pain—Furosemide—dilated cardiomyopathy	0.00572	0.00604	CcSEcCtD
Esomeprazole—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00566	0.00597	CcSEcCtD
Esomeprazole—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00552	0.00583	CcSEcCtD
Esomeprazole—Proteinuria—Lisinopril—dilated cardiomyopathy	0.0054	0.0057	CcSEcCtD
Esomeprazole—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00536	0.00566	CcSEcCtD
Esomeprazole—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00533	0.00562	CcSEcCtD
Esomeprazole—Polyuria—Furosemide—dilated cardiomyopathy	0.00523	0.00552	CcSEcCtD
Esomeprazole—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00523	0.00552	CcSEcCtD
Esomeprazole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00522	0.00551	CcSEcCtD
Esomeprazole—Swelling—Furosemide—dilated cardiomyopathy	0.00521	0.00549	CcSEcCtD
Esomeprazole—Alopecia—Spironolactone—dilated cardiomyopathy	0.00516	0.00545	CcSEcCtD
Esomeprazole—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00513	0.00542	CcSEcCtD
Esomeprazole—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00509	0.00537	CcSEcCtD
Esomeprazole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00505	0.00533	CcSEcCtD
Esomeprazole—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00499	0.00526	CcSEcCtD
Esomeprazole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00489	0.00516	CcSEcCtD
Esomeprazole—Thirst—Furosemide—dilated cardiomyopathy	0.00482	0.00509	CcSEcCtD
Esomeprazole—Purpura—Furosemide—dilated cardiomyopathy	0.00476	0.00503	CcSEcCtD
Esomeprazole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00472	0.00498	CcSEcCtD
Esomeprazole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00464	0.00489	CcSEcCtD
Esomeprazole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00461	0.00487	CcSEcCtD
Esomeprazole—Malaise—Spironolactone—dilated cardiomyopathy	0.00458	0.00484	CcSEcCtD
Esomeprazole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00458	0.00484	CcSEcCtD
Esomeprazole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00455	0.0048	CcSEcCtD
Esomeprazole—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00451	0.00476	CcSEcCtD
Esomeprazole—Irritability—Furosemide—dilated cardiomyopathy	0.00438	0.00463	CcSEcCtD
Esomeprazole—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.0043	0.00454	CcSEcCtD
Esomeprazole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00429	0.00453	CcSEcCtD
Esomeprazole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00428	0.00451	CcSEcCtD
Esomeprazole—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00425	0.00448	CcSEcCtD
Esomeprazole—Confusional state—Spironolactone—dilated cardiomyopathy	0.00418	0.00441	CcSEcCtD
Esomeprazole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00418	0.00441	CcSEcCtD
Esomeprazole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00416	0.00439	CcSEcCtD
Esomeprazole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00415	0.00438	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—RYR2—dilated cardiomyopathy	0.00414	0.0788	CbGpPWpGaD
Esomeprazole—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00413	0.00436	CcSEcCtD
Esomeprazole—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00413	0.00436	CcSEcCtD
Esomeprazole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00406	0.00429	CcSEcCtD
Esomeprazole—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00405	0.00427	CcSEcCtD
Esomeprazole—ATP4B—Ion channel transport—PLN—dilated cardiomyopathy	0.00403	0.0766	CbGpPWpGaD
Esomeprazole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.004	0.00422	CcSEcCtD
Esomeprazole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00398	0.0042	CcSEcCtD
Esomeprazole—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00394	0.00416	CcSEcCtD
Esomeprazole—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00392	0.00414	CcSEcCtD
Esomeprazole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00389	0.00411	CcSEcCtD
Esomeprazole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00389	0.0041	CcSEcCtD
Esomeprazole—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00383	0.00405	CcSEcCtD
Esomeprazole—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00382	0.00403	CcSEcCtD
Esomeprazole—Injury—Lisinopril—dilated cardiomyopathy	0.00375	0.00396	CcSEcCtD
Esomeprazole—ATP4A—Ion channel transport—RYR2—dilated cardiomyopathy	0.00369	0.0702	CbGpPWpGaD
Esomeprazole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00369	0.00389	CcSEcCtD
Esomeprazole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00367	0.00387	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00362	0.00382	CcSEcCtD
Esomeprazole—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00362	0.00382	CcSEcCtD
Esomeprazole—ATP4A—Ion channel transport—PLN—dilated cardiomyopathy	0.00359	0.0683	CbGpPWpGaD
Esomeprazole—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00358	0.00378	CcSEcCtD
Esomeprazole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00355	0.00374	CcSEcCtD
Esomeprazole—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00353	0.00373	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00351	0.0037	CcSEcCtD
Esomeprazole—Renal failure—Furosemide—dilated cardiomyopathy	0.00348	0.00367	CcSEcCtD
Esomeprazole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00346	0.00365	CcSEcCtD
Esomeprazole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00345	0.00364	CcSEcCtD
Esomeprazole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00345	0.00364	CcSEcCtD
Esomeprazole—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00345	0.00364	CcSEcCtD
Esomeprazole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00342	0.00361	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00335	0.00353	CcSEcCtD
Esomeprazole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00333	0.00351	CcSEcCtD
Esomeprazole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0033	0.00349	CcSEcCtD
Esomeprazole—Urticaria—Spironolactone—dilated cardiomyopathy	0.0033	0.00348	CcSEcCtD
Esomeprazole—Irritability—Lisinopril—dilated cardiomyopathy	0.00329	0.00347	CcSEcCtD
Esomeprazole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00328	0.00346	CcSEcCtD
Esomeprazole—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00323	0.00341	CcSEcCtD
Esomeprazole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00314	0.00331	CcSEcCtD
Esomeprazole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00311	0.00329	CcSEcCtD
Esomeprazole—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00311	0.00329	CcSEcCtD
Esomeprazole—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.0031	0.00327	CcSEcCtD
Esomeprazole—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.0031	0.00327	CcSEcCtD
Esomeprazole—Visual impairment—Furosemide—dilated cardiomyopathy	0.00306	0.00323	CcSEcCtD
Esomeprazole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00306	0.00323	CcSEcCtD
Esomeprazole—Gastritis—Lisinopril—dilated cardiomyopathy	0.00305	0.00322	CcSEcCtD
Esomeprazole—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.003	0.00317	CcSEcCtD
Esomeprazole—Asthma—Lisinopril—dilated cardiomyopathy	0.00298	0.00314	CcSEcCtD
Esomeprazole—Influenza—Lisinopril—dilated cardiomyopathy	0.00298	0.00314	CcSEcCtD
Esomeprazole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00297	0.00313	CcSEcCtD
Esomeprazole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00296	0.00313	CcSEcCtD
Esomeprazole—Pruritus—Spironolactone—dilated cardiomyopathy	0.00293	0.0031	CcSEcCtD
Esomeprazole—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00293	0.00309	CcSEcCtD
Esomeprazole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00292	0.00308	CcSEcCtD
Esomeprazole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.0029	0.00306	CcSEcCtD
Esomeprazole—Sweating increased—Lisinopril—dilated cardiomyopathy	0.0029	0.00306	CcSEcCtD
Esomeprazole—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00287	0.00303	CcSEcCtD
Esomeprazole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00284	0.003	CcSEcCtD
Esomeprazole—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00283	0.00298	CcSEcCtD
Esomeprazole—Dysuria—Lisinopril—dilated cardiomyopathy	0.00278	0.00294	CcSEcCtD
Esomeprazole—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00278	0.00294	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00277	0.00292	CcSEcCtD
Esomeprazole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00277	0.00292	CcSEcCtD
Esomeprazole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00274	0.0029	CcSEcCtD
Esomeprazole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00274	0.00289	CcSEcCtD
Esomeprazole—Flatulence—Furosemide—dilated cardiomyopathy	0.00272	0.00288	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00272	0.00287	CcSEcCtD
Esomeprazole—Weight increased—Lisinopril—dilated cardiomyopathy	0.00271	0.00286	CcSEcCtD
Esomeprazole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00271	0.00286	CcSEcCtD
Esomeprazole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00269	0.00284	CcSEcCtD
Esomeprazole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00266	0.00281	CcSEcCtD
Esomeprazole—Depression—Lisinopril—dilated cardiomyopathy	0.00265	0.00279	CcSEcCtD
Esomeprazole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00264	0.00278	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00263	0.00278	CcSEcCtD
Esomeprazole—Rash—Spironolactone—dilated cardiomyopathy	0.00262	0.00276	CcSEcCtD
Esomeprazole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00261	0.00276	CcSEcCtD
Esomeprazole—Renal failure—Lisinopril—dilated cardiomyopathy	0.00261	0.00275	CcSEcCtD
Esomeprazole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00261	0.00275	CcSEcCtD
Esomeprazole—Headache—Spironolactone—dilated cardiomyopathy	0.0026	0.00274	CcSEcCtD
Esomeprazole—Jaundice—Lisinopril—dilated cardiomyopathy	0.00259	0.00273	CcSEcCtD
Esomeprazole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00258	0.00272	CcSEcCtD
Esomeprazole—Anaemia—Furosemide—dilated cardiomyopathy	0.00256	0.0027	CcSEcCtD
Esomeprazole—Agitation—Furosemide—dilated cardiomyopathy	0.00254	0.00268	CcSEcCtD
Esomeprazole—Haematuria—Lisinopril—dilated cardiomyopathy	0.00253	0.00267	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00251	0.00265	CcSEcCtD
Esomeprazole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.0025	0.00264	CcSEcCtD
Esomeprazole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00249	0.00263	CcSEcCtD
Esomeprazole—Vertigo—Furosemide—dilated cardiomyopathy	0.00248	0.00262	CcSEcCtD
Esomeprazole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00248	0.00262	CcSEcCtD
Esomeprazole—Leukopenia—Furosemide—dilated cardiomyopathy	0.00248	0.00261	CcSEcCtD
Esomeprazole—Nausea—Spironolactone—dilated cardiomyopathy	0.00246	0.0026	CcSEcCtD
Esomeprazole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00243	0.00256	CcSEcCtD
Esomeprazole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00239	0.00252	CcSEcCtD
Esomeprazole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00238	0.00252	CcSEcCtD
Esomeprazole—Hallucination—Lisinopril—dilated cardiomyopathy	0.00237	0.0025	CcSEcCtD
Esomeprazole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00237	0.0025	CcSEcCtD
Esomeprazole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00235	0.00248	CcSEcCtD
Esomeprazole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00235	0.00248	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00234	0.00247	CcSEcCtD
Esomeprazole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00234	0.00247	CcSEcCtD
Esomeprazole—Dry mouth—Furosemide—dilated cardiomyopathy	0.0023	0.00243	CcSEcCtD
Esomeprazole—Confusional state—Furosemide—dilated cardiomyopathy	0.00228	0.0024	CcSEcCtD
Esomeprazole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00226	0.00238	CcSEcCtD
Esomeprazole—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00225	0.00238	CcSEcCtD
Esomeprazole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00222	0.00235	CcSEcCtD
Esomeprazole—Shock—Furosemide—dilated cardiomyopathy	0.00222	0.00234	CcSEcCtD
Esomeprazole—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00221	0.00234	CcSEcCtD
Esomeprazole—Flushing—Lisinopril—dilated cardiomyopathy	0.00221	0.00233	CcSEcCtD
Esomeprazole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00221	0.00233	CcSEcCtD
Esomeprazole—Skin disorder—Furosemide—dilated cardiomyopathy	0.00219	0.00231	CcSEcCtD
Esomeprazole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00218	0.0023	CcSEcCtD
Esomeprazole—Anorexia—Furosemide—dilated cardiomyopathy	0.00215	0.00227	CcSEcCtD
Esomeprazole—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00215	0.00227	CcSEcCtD
Esomeprazole—Chills—Lisinopril—dilated cardiomyopathy	0.00214	0.00226	CcSEcCtD
Esomeprazole—Alopecia—Lisinopril—dilated cardiomyopathy	0.00211	0.00222	CcSEcCtD
Esomeprazole—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00209	0.0022	CcSEcCtD
Esomeprazole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00207	0.00219	CcSEcCtD
Esomeprazole—Flatulence—Lisinopril—dilated cardiomyopathy	0.00204	0.00216	CcSEcCtD
Esomeprazole—Tension—Lisinopril—dilated cardiomyopathy	0.00204	0.00215	CcSEcCtD
Esomeprazole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00203	0.00214	CcSEcCtD
Esomeprazole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00203	0.00214	CcSEcCtD
Esomeprazole—Nervousness—Lisinopril—dilated cardiomyopathy	0.00202	0.00213	CcSEcCtD
Esomeprazole—Back pain—Lisinopril—dilated cardiomyopathy	0.00201	0.00212	CcSEcCtD
Esomeprazole—Somnolence—Furosemide—dilated cardiomyopathy	0.00201	0.00212	CcSEcCtD
Esomeprazole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00199	0.00211	CcSEcCtD
Esomeprazole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00196	0.00207	CcSEcCtD
Esomeprazole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00196	0.00206	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00195	0.00206	CcSEcCtD
Esomeprazole—Fatigue—Furosemide—dilated cardiomyopathy	0.00195	0.00205	CcSEcCtD
Esomeprazole—Tremor—Lisinopril—dilated cardiomyopathy	0.00194	0.00205	CcSEcCtD
Esomeprazole—Pain—Furosemide—dilated cardiomyopathy	0.00193	0.00204	CcSEcCtD
Esomeprazole—Constipation—Furosemide—dilated cardiomyopathy	0.00193	0.00204	CcSEcCtD
Esomeprazole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00193	0.00203	CcSEcCtD
Esomeprazole—Anaemia—Lisinopril—dilated cardiomyopathy	0.00192	0.00202	CcSEcCtD
Esomeprazole—Angioedema—Lisinopril—dilated cardiomyopathy	0.0019	0.002	CcSEcCtD
Esomeprazole—Malaise—Lisinopril—dilated cardiomyopathy	0.00187	0.00197	CcSEcCtD
Esomeprazole—Vertigo—Lisinopril—dilated cardiomyopathy	0.00186	0.00197	CcSEcCtD
Esomeprazole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00186	0.00196	CcSEcCtD
Esomeprazole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00186	0.00196	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00185	0.00195	CcSEcCtD
Esomeprazole—Palpitations—Lisinopril—dilated cardiomyopathy	0.00183	0.00194	CcSEcCtD
Esomeprazole—Cough—Lisinopril—dilated cardiomyopathy	0.00181	0.00191	CcSEcCtD
Esomeprazole—Urticaria—Furosemide—dilated cardiomyopathy	0.00179	0.00189	CcSEcCtD
Esomeprazole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00178	0.00188	CcSEcCtD
Esomeprazole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00178	0.00188	CcSEcCtD
Esomeprazole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00177	0.00186	CcSEcCtD
Esomeprazole—Myalgia—Lisinopril—dilated cardiomyopathy	0.00177	0.00186	CcSEcCtD
Esomeprazole—Chest pain—Lisinopril—dilated cardiomyopathy	0.00177	0.00186	CcSEcCtD
Esomeprazole—Anxiety—Lisinopril—dilated cardiomyopathy	0.00176	0.00186	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00175	0.00185	CcSEcCtD
Esomeprazole—Discomfort—Lisinopril—dilated cardiomyopathy	0.00175	0.00184	CcSEcCtD
Esomeprazole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00173	0.00182	CcSEcCtD
Esomeprazole—Confusional state—Lisinopril—dilated cardiomyopathy	0.00171	0.0018	CcSEcCtD
Esomeprazole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00169	0.00179	CcSEcCtD
Esomeprazole—Infection—Lisinopril—dilated cardiomyopathy	0.00168	0.00178	CcSEcCtD
Esomeprazole—Shock—Lisinopril—dilated cardiomyopathy	0.00167	0.00176	CcSEcCtD
Esomeprazole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00166	0.00176	CcSEcCtD
Esomeprazole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00166	0.00175	CcSEcCtD
Esomeprazole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00165	0.00174	CcSEcCtD
Esomeprazole—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00164	0.00174	CcSEcCtD
Esomeprazole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00164	0.00173	CcSEcCtD
Esomeprazole—Asthenia—Furosemide—dilated cardiomyopathy	0.00162	0.00171	CcSEcCtD
Esomeprazole—Anorexia—Lisinopril—dilated cardiomyopathy	0.00161	0.0017	CcSEcCtD
Esomeprazole—Pruritus—Furosemide—dilated cardiomyopathy	0.0016	0.00169	CcSEcCtD
Esomeprazole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00154	0.00163	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00154	0.00163	CcSEcCtD
Esomeprazole—Insomnia—Lisinopril—dilated cardiomyopathy	0.00153	0.00162	CcSEcCtD
Esomeprazole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00152	0.0016	CcSEcCtD
Esomeprazole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00151	0.00159	CcSEcCtD
Esomeprazole—Somnolence—Lisinopril—dilated cardiomyopathy	0.00151	0.00159	CcSEcCtD
Esomeprazole—Dizziness—Furosemide—dilated cardiomyopathy	0.00149	0.00158	CcSEcCtD
Esomeprazole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00149	0.00157	CcSEcCtD
Esomeprazole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00147	0.00155	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00146	0.00154	CcSEcCtD
Esomeprazole—Fatigue—Lisinopril—dilated cardiomyopathy	0.00146	0.00154	CcSEcCtD
Esomeprazole—Constipation—Lisinopril—dilated cardiomyopathy	0.00145	0.00153	CcSEcCtD
Esomeprazole—Pain—Lisinopril—dilated cardiomyopathy	0.00145	0.00153	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00144	0.0274	CbGpPWpGaD
Esomeprazole—Vomiting—Furosemide—dilated cardiomyopathy	0.00143	0.00151	CcSEcCtD
Esomeprazole—Rash—Furosemide—dilated cardiomyopathy	0.00142	0.0015	CcSEcCtD
Esomeprazole—Dermatitis—Furosemide—dilated cardiomyopathy	0.00142	0.0015	CcSEcCtD
Esomeprazole—Headache—Furosemide—dilated cardiomyopathy	0.00141	0.00149	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0014	0.0267	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0014	0.0267	CbGpPWpGaD
Esomeprazole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0014	0.00147	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00138	0.00146	CcSEcCtD
Esomeprazole—Urticaria—Lisinopril—dilated cardiomyopathy	0.00135	0.00142	CcSEcCtD
Esomeprazole—Nausea—Furosemide—dilated cardiomyopathy	0.00134	0.00141	CcSEcCtD
Esomeprazole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00134	0.00141	CcSEcCtD
Esomeprazole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00134	0.00141	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.0013	0.0248	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00128	0.0244	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00125	0.0238	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00125	0.0238	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00125	0.00132	CcSEcCtD
Esomeprazole—Asthenia—Lisinopril—dilated cardiomyopathy	0.00121	0.00128	CcSEcCtD
Esomeprazole—Pruritus—Lisinopril—dilated cardiomyopathy	0.0012	0.00126	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00116	0.0221	CbGpPWpGaD
Esomeprazole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00116	0.00122	CcSEcCtD
Esomeprazole—Dizziness—Lisinopril—dilated cardiomyopathy	0.00112	0.00118	CcSEcCtD
Esomeprazole—Vomiting—Lisinopril—dilated cardiomyopathy	0.00108	0.00114	CcSEcCtD
Esomeprazole—Rash—Lisinopril—dilated cardiomyopathy	0.00107	0.00113	CcSEcCtD
Esomeprazole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00107	0.00113	CcSEcCtD
Esomeprazole—Headache—Lisinopril—dilated cardiomyopathy	0.00106	0.00112	CcSEcCtD
Esomeprazole—Nausea—Lisinopril—dilated cardiomyopathy	0.00101	0.00106	CcSEcCtD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000894	0.017	CbGpPWpGaD
Esomeprazole—ATP4B—Ion channel transport—RAF1—dilated cardiomyopathy	0.000817	0.0155	CbGpPWpGaD
Esomeprazole—ATP4A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000728	0.0138	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000396	0.00754	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000284	0.00541	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000253	0.00482	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000245	0.00466	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00023	0.00438	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000109	0.00208	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000103	0.00195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	9.28e-05	0.00177	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.56e-05	0.00125	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.17e-05	0.00117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.66e-05	0.00108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.58e-05	0.00106	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.51e-05	0.00105	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.96e-05	0.000944	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.52e-05	0.00048	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.46e-05	0.000467	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.21e-05	0.000421	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.52e-05	0.000288	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.48e-05	0.000281	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.33e-05	0.000253	CbGpPWpGaD
